Search clinical trials for: Fuji IX

Total 104 results

Cairo University

Completed

Evaluation of Biodentine Versus Glass Ionomer Cement in Treatment of Very Deep Carious Lesions

Deep Caries

Egypt
Mathilde Peters, DMD, PhD
Dentsply International; Mott Children's Health Center

Completed

High-strength Glass-ionomer Dental Restorations (ROCK)

Dental Caries

United States
Marina F Fahmy, MD

Completed

Fluoride Release,Compressive Strength and Clinical Performance of a Bioactive Restorative Material in ART

Dental Caries

Egypt
University of Sao Paulo

Unknown

Cost-efficacy Between ART and Composite Resin Restorations in Primary Molars

Dental Caries

Brazil
University of Sao Paulo
Academic Centre for Dentistry in Amsterdam

Completed

Occlusal ART Restorations in Primary Molars Using 3 Different GIC

Dental Caries

Brazil
Liaquat University of Medical & Health Sciences

Recruiting

Postoperative Sensitivity Following Placement With Different Restorative Materials In Vital Posterior Teeth (GCP)

Sensitivity, Tooth

Pakistan
Louisiana State University Health Sciences Center...

Unknown

Clinical Retention of Glass Ionomer Sealants Placed With and Without Rubber Dam: a Comparative Analysis

Dental Caries in Children
Cairo University

Active, not recruiting

Evaluation of Conservative Management of Teeth With Deep Cavitated Carious Lesions

Deep Caries | Pulp Exposure, Dental

Egypt
Ixchelsis Limited

Completed

IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT), Patient Reported Outcomes and Safety in Men With Premature Ejaculation (PE)

Premature Ejaculation

United States
Imperial College London

Completed

Adjuvant Benefit of NMES to Supervised Exercise in Patients With IC (AdjIC)

Intermittent Claudication | Peripheral Vascular Disease | Lower Limb Arterial Disease

United Kingdom
Imperial College London
Actegy Ltd.

Completed

REVITIVE for the Treatment of Patients With Venous Insufficiency (RVI)

Varicose Veins | Venous Insufficiency | Oedema

United Kingdom
Universidade Federal de Santa Catarina

Completed

Consumption of Apple Juice in Hemodialysis Patients

Oxidative Stress
Bioverativ Therapeutics Inc.
Swedish Orphan Biovitrum

Completed

Study of Recombinant Factor IX Fc Fusion Protein (rFIXFc) in Participants With Hemophilia B

Severe Hemophilia B

Sweden, United States, France, Italy, Russian Federation, United Kingdom, Germany, China, Poland, Japan, Australia, Brazil, Canada, India, South Africa, Hong Kong, Belgium
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Completed

RIXUBIS PMS India (RIXUBIS PMS)

Hemophilia B

India
Laval University

Completed

Physiology of Lung Collapse Under One-Lung Ventilation: Underlying Mechanisms (PLC-OLV)

Thoracic Surgery | One-Lung Ventilation | Lung Collapse | Video-Assisted

Canada
Ixchelsis Limited

Completed

Relative Bioavailability and Food Effect Study of IX-01 Capsules in Healthy Men

Healthy Participants

United Kingdom
Ixchelsis Limited
HealthCore-NERI; Novotech (Australia) Pty Limited; ICON plc; PHT Corporation

Completed

IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)

Premature Ejaculation

United States, Australia
King's College London

Unknown

Efficacy of Calcium Silicate Pulp-capping; a Randomized Controlled Clinical Trial

Reversible Pulpitis

United Kingdom
Imperial College London

Terminated

Neuromuscular Electrical Stimulation in Patients With Critical Limb Ischaemia

Peripheral Arterial Disease | Critical Limb Ischaemia

United Kingdom
Baxalta now part of Shire
Takeda

Completed

RIXUBIS Drug Use-Result Survey (Japan)

Hemophilia B

Japan
Hacettepe University

Active, not recruiting

Clinical Evaluation of a Restorative Glass Ionomer and a Composite Resin for the Restoration

Tooth Disease

Turkey
Catalyst Biosciences

Completed

Study of Next-Generation Recombinant Factor IX Variant in Adult Subjects With Hemophilia B

Hemophilia B

South Africa
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating BENEFIX in Previously Treated Patients With Hemophilia B

Hemophilia B
Ixchelsis Limited

Completed

A Study of Multiple Oral Doses of IX-01 in Healthy Male Subjects

Healthy Volunteers

United Kingdom
Ixchelsis Limited

Completed

A Study of Multiple Oral Doses of IX-01 in Healthy Men

Healthy Participants

United Kingdom
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating BeneFIX in Patients With Haemophilia B, Previously Treated With Plasma Derived Factor IX

Hemophilia B

France
Izmir Katip Celebi University

Completed

Clinical Efficacy of Different Fissure Sealant Materials in the Newly Erupted Non-Carious First Permanent Molars

Fissure Sealant

Turkey
Bioverativ Therapeutics Inc.
Swedish Orphan Biovitrum

Completed

Study of Recombinant Coagulation Factor IX Fc Fusion Protein, BIIB029, in Previously Treated Pediatric Participants With Hemophilia B (Kids B-LONG)

Hemophilia B

United States, United Kingdom, South Africa, Netherlands, Ireland, Australia
University Health Network, Toronto

Completed

A Clinical Comparison of Two New Bronchial Blockers vs. Double Lumen Tubes in One Lung Ventilation

Thoracic Surgery, Lung Isolation

Canada
Isabel Cristina Olegário da Costa
University of Guadalajara; University of Dublin, Trinity College; Academic Centre...

Unknown

Glass Ionomer Cement Sealant in the Prevention of Post-eruptive Fractures in Molars Affected by MIH (MIHMex)

Molar Incisor Hypomineralization

Mexico
Convergent Genomics, Inc.

Completed

Comparison of EPM-IX to Currently Used Specimen Transportation and Extraction Devices ( CGI-EPM-IX ) (CGI-EPM-IX)

SARS-CoV-2

United States
Medexus Pharma, Inc.

Terminated

Study of Recombinant Factor IX Product, IB1001, in Previously Treated Pediatric Subjects With Hemophilia B

Hemophilia B

United States, United Kingdom, India
Grifols Biologicals, LLC

Completed

Efficacy and Safety of AlphaNine Versus BeneFIX in Patients With Severe Hereditary Haemophilia B

Hemophilia B

Bulgaria
Pfizer

Completed

Post Marketing Surveillance To Observe Safety and Efficacy Of BeneFIX In Patients With Hemophilia B

Hemophilia B

Korea, Republic of
Ixchelsis Limited

Completed

Relative Bioavailability Study of IX-01 Caplet Versus Aqueous Dispersion and Food Effect of the Caplet in Healthy Males (IX-0106 RBA)

Healthy

United States
Imperial College London
Actegy Ltd.

Completed

DESIVI: Dosing of Electrical Stimulation in Venous Insufficiency (DESIVI)

Varicose Veins | Venous Insufficiency | Venous Stasis
Pfizer

Completed

Study Comparing On-Demand Treatment With Two Prophylaxis Regimens Of BeneFIX In Patients With Severe Hemophilia B

Hemophilia B

United States, Spain, Croatia, Serbia, Russian Federation, Canada, Hungary, Italy, Romania
National Center for Research Resources (NCRR)
University of North Carolina

Completed

Phase I/II Study of Monoclonal Factor IX Concentrate for Factor IX Deficiency

Hemophilia B | Factor IX Deficiency
Sanquin-LUMC J.J van Rood Center for Clinical Transfusion...
Leiden University Medical Center

Completed

Insufficient Oxygenation in Septic Patients (INOX-SEPSIS)

Sepsis | Fluid Therapy | Critical Care | Oxygen | Mitochondria

Netherlands
Bio Products Laboratory

Completed

A Study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Patients Under the Age of 6 Years

Haemophilia B

Poland, Ukraine
Bio Products Laboratory

Completed

A Study to Compare the Pharmacokinetics and Safety of Replenine®-VF, Replenine® or Other Factor IX in Haemophilia B

Haemophilia B

United Kingdom
Ege University

Completed

6-year Clinical Evaluation of Glass Ionomer Cements (GIS) With Resin Coating on Posterior Teeth (GIS)

Dental Caries
Medexus Pharma, Inc.

Completed

Evaluation of a Recombinant Factor IX Product, APVO101, in Previously-Treated Pediatric Patients With Hemophilia B

Hemophilia B

Turkey, Brazil, Georgia, Moldova, Republic of, South Africa, Ukraine
Mayo Clinic
Fujifilm Medical Systems USA, Inc.

Completed

Minimal Risk Registry of Endoscopic Image and Pathology Correlation for Fujiflim

Gastro-Intestinal Disorder

United States
Dartmouth-Hitchcock Medical Center

Enrolling by invitation

Portable Measurement of Protoporphyrin IX in the Skin

Photodynamic Therapy | Protoporphyrin IX

United States
Imam Abdulrahman Bin Faisal University

Completed

Selective Lobar Blockade and Bronchial Blockers

One Lung Ventilation | Elective Thoracic Surgery

Saudi Arabia
Tulane University
Genentech, Inc.

Recruiting

Factor IX as Adjunctive Therapy to Emicizumab (EMIX)

Hemophilia A

United States
Baxalta now part of Shire

Completed

IMMUNINE Pre-Treatment Study

Hemophilia B

Colombia, Bulgaria, Chile, Poland, Romania, Argentina, Brazil, Czechia, Russian Federation, Ukraine
Bio Products Laboratory

Completed

An Open Study to Investigate the Safety and Efficacy of Replenine®-VF in Severe Haemophilia B Patients

Haemophilia B

United Kingdom, Poland
Bio Products Laboratory

Completed

An Open-study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Subjects Undergoing Surgery

Haemophilia B

Poland, Romania, Russian Federation

Search clinical trials for: Fuji IX

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations